PH27178A - A pharmaceutical composition including basic placenta angiogenic factor and heparin - Google Patents

A pharmaceutical composition including basic placenta angiogenic factor and heparin Download PDF

Info

Publication number
PH27178A
PH27178A PH36009A PH36009A PH27178A PH 27178 A PH27178 A PH 27178A PH 36009 A PH36009 A PH 36009A PH 36009 A PH36009 A PH 36009A PH 27178 A PH27178 A PH 27178A
Authority
PH
Philippines
Prior art keywords
tpa
cells
paf
tha
heparin
Prior art date
Application number
PH36009A
Other languages
English (en)
Inventor
David A Moscatelli
Daniel B Rifkin
David F Carmichael
Original Assignee
David A. Moscatelli
Daniel B. Rifkin
David F. Carmichael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David A. Moscatelli, Daniel B. Rifkin, David F. Carmichael filed Critical David A. Moscatelli
Publication of PH27178A publication Critical patent/PH27178A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
PH36009A 1986-10-31 1987-10-30 A pharmaceutical composition including basic placenta angiogenic factor and heparin PH27178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92525986A 1986-10-31 1986-10-31

Publications (1)

Publication Number Publication Date
PH27178A true PH27178A (en) 1993-04-02

Family

ID=25451470

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36009A PH27178A (en) 1986-10-31 1987-10-30 A pharmaceutical composition including basic placenta angiogenic factor and heparin

Country Status (4)

Country Link
AU (1) AU8272887A (fr)
CA (1) CA1319610C (fr)
PH (1) PH27178A (fr)
WO (1) WO1988003030A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1263452A4 (fr) * 2000-02-08 2006-12-20 Univ Northwestern Procedes et compositions permettant de produire de l'angiostatine

Also Published As

Publication number Publication date
WO1988003030A1 (fr) 1988-05-05
CA1319610C (fr) 1993-06-29
AU8272887A (en) 1988-05-25

Similar Documents

Publication Publication Date Title
Ludlam et al. Factor VIII and fibrinolytic response to deamino‐8‐D‐argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease
Sgouris et al. The preparation of human fibrinolysin (plasmin)
Colucci et al. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
KR950010322B1 (ko) 안정화된 인체 조직 플라스미노겐 활성제 조성물
AU2008203028B2 (en) Pharmaceutically stable hemostatic compositions
FI85335C (fi) Foerfarande foer framstaellning av lyofiliserad, farmaceutisk vaevnadsplasminogenaktivator(t-pa)-komposition.
WO1998048818A1 (fr) Formulations de proteine activee
EP0463152A1 (fr) Procede inhibiteur de l'angiogenese tumorale.
US5155038A (en) Use of thrombospondin to promote wound healing
EP0317053B1 (fr) Trigramine, un polypeptide inhibant l'aggrégation des plaquettes
US8809510B2 (en) Method for purification of complement factor H
JP4129994B2 (ja) 組織因子凝固系インヒビター含有血管新生阻害剤
Fehrenbacher et al. Synthesis of plasminogen activator by bovine corneal endothelial cells
Dupe et al. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis
Sano et al. Immunolocalization of cathepsins B, H and L in skeletal muscle of X-linked muscular dystrophy (mdx) mouse
PH27178A (en) A pharmaceutical composition including basic placenta angiogenic factor and heparin
EP0099126A2 (fr) Composition thrombolytique
CA1322163C (fr) Production d'activateurs du plasminogene
JP2002529424A (ja) 血液凝固障害を処置するためのレセプタ−アンタゴニストを含む薬学的調製物
JPS62153224A (ja) プラスミノゲン製剤
US6750201B1 (en) Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
JPH0739387A (ja) 腫瘍の境界位置決定試薬及び腫瘍の治療剤
JPH07502989A (ja) 血友病の治療
EP0948342B1 (fr) UTILISATIONS EN MEDECINE DU COMPLEXE scuPA/scuPAR
JPS6338327B2 (fr)